Improving immunotherapy by targeting the immunosuppressive fibroblasts in lung cancer
Associate researcher: Jordi Alcaraz (jalcaraz@ub.edu) Co-supervisor: Joan Montero/Josep Samitier Lung cancer is the first cause of cancer death in developed countries, with a 5-year survival rate of ~18%. Promising therapeutic … Read more